rs79761183
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_018100.4(EFHC1):c.662G>A(p.Arg221His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00132 in 1,614,130 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R221C) has been classified as Likely benign.
Frequency
Consequence
NM_018100.4 missense
Scores
Clinical Significance
Conservation
Publications
- juvenile myoclonic epilepsyInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- epilepsyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| EFHC1 | NM_018100.4 | c.662G>A | p.Arg221His | missense_variant | Exon 4 of 11 | ENST00000371068.11 | NP_060570.2 | |
| EFHC1 | NM_001172420.2 | c.605G>A | p.Arg202His | missense_variant | Exon 5 of 12 | NP_001165891.1 | ||
| EFHC1 | NR_033327.2 | n.731G>A | non_coding_transcript_exon_variant | Exon 4 of 10 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00711 AC: 1082AN: 152156Hom.: 21 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00197 AC: 495AN: 251412 AF XY: 0.00161 show subpopulations
GnomAD4 exome AF: 0.000716 AC: 1046AN: 1461856Hom.: 11 Cov.: 32 AF XY: 0.000656 AC XY: 477AN XY: 727232 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00710 AC: 1081AN: 152274Hom.: 21 Cov.: 32 AF XY: 0.00685 AC XY: 510AN XY: 74452 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:3Other:1
- -
- -
p.Arg221His (CGT>CAT): c.662 G>A in exon 4 of the EFHC1 gene (NM_018100.3). P77T and R221H were identified on the same chromosome and co-segregated with juvenile myoclonic epilepsy (JME) in two families (Suzuki et al., 2004). Functional studies suggest that both P77T and R221H impair apoptosis and alter calcium currents (Suzuki et al., 2004). However, both P77T and R221H have subsequently been identified in 1-3% of the African population in the NHLBI ESP Exome Variant Project and the 1000 Genomes Database. P77T results in a nonconservative amino acid substitution, while the R221H substitution is a conservative change. Both of these missense substitutions alter positions in the protein that are not highly conserved throughout evolution or in related proteins, and multiple in silico models predict they are likely benign. Therefore, currently available evidence suggests that P77T and R221H may be associated with JME, although the possibility that they are benign variants cannot be completely excluded. The variant is found in CHILD-EPI,EPILEPSY,INFANT-EPI panel(s). -
- -
not specified Benign:2
- -
- -
Absence seizure;C1850778:Myoclonic epilepsy, juvenile, susceptibility to, 1 Benign:1
- -
EFHC1-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at